You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

The product is approved for post-exposure prophylaxis against rabies infection

read more 

EVENTS

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

A crowded symposium dedicated to the SIPPET Study was held on July 9th

read more 
  1. CORPORATE - 18-01-2016

    A brand new location for KEDPlasma donors in the very center of Fürth

    Plasma collected is turned into life-saving therapies to serve patients in Germany and worldwide

    read more 
  2. CORPORATE - 08-01-2016

    KEDPlasma acquires two plasma centers from ImmunoTek LLC in the US

    The acquisition is part of a five-year growth plan of supplying highest-quality plasma to Kedrion Biopharma

    read more 
  3. CORPORATE - 07-01-2016

    Human rabies Ig meets primary endpoint in U.S. pivotal phase 2/3 clinical trial

    Strategic agreement between Kedrion and Kamada for its clinical development and marketing

    read more 
  4. EVENTS - 07-12-2015

    Hemophilia A. SIPPET study selected by the American Society of Hematology

    Presented at the ASH Congress in Orlando, it was chosen from amongst approximately three thousand studies

    read more 

Pages

For more information please contact: pressoffice@kedrion.com